t e c h n i c a l r e p o r t s
Orthotopic liver transplantation is the only available treatment for severe liver failure, but it is currently limited by organ shortage. One technical challenge that has thus far limited the development of a tissue-engineered liver graft is oxygen and nutrient transport. Here we demonstrate a novel approach to generate transplantable liver grafts using decellularized liver matrix. The decellularization process preserves the structural and functional characteristics of the native microvascular network, allowing efficient recellularization of the liver matrix with adult hepatocytes and subsequent perfusion for in vitro culture. The recellularized graft supports liver-specific function including albumin secretion, urea synthesis and cytochrome P450 expression at comparable levels to normal liver in vitro. The recellularized liver grafts can be transplanted into rats, supporting hepatocyte survival and function with minimal ischemic damage. These results provide a proof of principle for the generation of a transplantable liver graft as a potential treatment for liver disease.
About thirty million people in the United States have liver dis order, with roughly 27,000 deaths registered annually due to liver disease 1 . The only definitive treatment for severe hepatic failure is transplantation. However, critical shortage of organs causes a growing deficit of approximately 4,000 livers per year 2 . Hepatocyte transplantation offers an alternative way to treat patients with liver diseases 3, 4 , and years of laboratory and clinical studies have demon strated its efficacy [5] [6] [7] . However, a limited cell supply and minimal engraftment efficiency have limited this approach 3, 8, 9 . Whereas the cell supply limitation can potentially be resolved by a number of alternative cell sources [10] [11] [12] [13] , low engraftment efficiency 14 remains a major concern.
Tissue engineering approaches have thus far been able to partially improve cell engraftment in animal models by enhancing celltocell contact and providing nonimmunogenic matrices before transplan tation 15 . However, these approaches have been limited by oxygen and nutrient diffusion to thin, twodimensional structures that are transplanted into highly vascularized regions [16] [17] [18] . Practical consid eration of primary hepatocyte oxygen consumption requires that any hepatic mass, sufficiently large to provide metabolic function, contains an extensive microvascular network and be connected to the blood supply, or the internal mass of the cells will suffer ischemic damage 19, 20 .
Decellularization is an attractive technique for scaffold preparation in tissue engineering, as the resulting material can potentially retain the architecture of the original tissue, including the functional aspects of the native microvasculature 21 . The potential applications of decellu larized matrix in tissue engineering have been demonstrated for a number of tissues, including bladder 22 , artery 23 , esophagus 24 , skin 25 and trachea 26 . More recently, another group reported the decellulari zation of an entire heart through perfusion, preserving the original architecture and original microvascular network and allowing for extensive recellularization 27 .
In this work, we modified and applied their perfusion decellulariza tion technique 27 to prepare whole liver grafts, and we further intro duced perfusionseeding and culture techniques for the preparation of recellularized liver matrix for transplantation. A key advantage of this methodology is the preservation of liverspecific extracellular matrix and threedimensional architecture, providing crucial cues for hepatocyte engraftment, survival and longterm function. Most importantly, the decellularized liver matrix (DLM) has the underlying matrix of the vascular network, which can be readily connected to the circulation, facilitating rapid oxygen and nutrient delivery after Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix transplantation. The large pool of donor organs unsuitable for trans plantation, such as donors after cardiac death, provides a source for decellularized liver matrices 28 , rendering this approach feasible.
Our work demonstrates the decellularization of ischemic rat livers by portal vein perfusion and its characterization. We show the preser vation of both structural and basement membrane-based compo nents of the native liver extracellular matrix, as well as the retention of a functional microvascular network. DLM supported efficient engraftment and in vitro metabolic function of adult primary hepato cytes. Retention of vascular structures allowed for transplantation of recellularized liver graft in rats, and posttransplantation analysis demonstrated preservation of hepatocyte structure and function with minimal indications of ischemic damage. Preliminary recellulariza tion with endothelial cells also indicated attachment and viability within the recellularized matrix in vitro. Overall, the methods and techniques developed in this study present what is to our knowledge the first step toward manufacture of auxiliary liver grafts as an alter native source of organs for liver transplantation.
RESULTS

Characterization of decellularized liver matrix
We achieved wholeorgan decellularization by portal perfusion with SDS, an anionic detergent that lyses cells and solubilizes cytoplasmic components 27 . After 72 h of decellularization, a translucent acel lular scaffold, which retained the gross shape of liver, was generated ( Fig. 1a-e) . Histological evaluation revealed no nuclei or cyto plasmic staining in DLM compared to normal rat liver (Fig. 1f) . Immunostaining for four extracellular matrix (ECM) proteins, collagen type I, collagen type IV, fibronectin and lamininβ1, indi cated that both structural and basement membrane components of the ECM were retained similarly to native liver (Fig. 1f) . A lack of DAPI staining in DLM confirmed the absence of cells (Fig. 1f) . We observed both collagen type IV and fibronectin in decellularized sinusoidal spaces, whereas we saw lamininβ1 in the basement membrane of the larger vessels (Fig. 1f) . We found that 100% of the fibrillar collagen and approximately 50% of the glycosaminoglycans of native liver were retained after decellularization (Supplementary Table 1 ). Residual DNA content in the DLM was less than 3% (Supplementary Table 1) .
To show that the decellularization protocol was successful in retain ing a functional vascular bed, we characterized its perfusion with Allura Red dye. Structural components of the vascular tree were clearly apparent in the translucent matrix (Fig. 2a,b) . The dye injected through the portal vein flowed as would be expected inside the vas cular network, gradually moving from larger vessels to smaller capil laries, suggesting the microvasculature remained intact. We further characterized the intricate vascular tree by generating a corrosion cast of DLM (Fig. 2c,d) . Portal (red) and venous (blue) vasculature casting of both normal (Fig. 2c) and decellularized ( Fig. 2d) livers showed that larger portal and venous circulation system of vessels and the vast majority of the smaller microcirculatory branches were preserved, indicating that physiologic flow could be achieved by traversing the portal venous system and emptying into the systemic venous circu lation via the hepatic vein and inferior vena cava (IVC). Moreover, scanning electron microscopy (SEM) images confirmed the presence of large vessels within DLM (Fig. 2e) , and we also observed remnants of small vessels closely resembling portal triad (Fig. 2f) . The honey comb of about 30μm diameter gaps in the ECM is thought to be the footprint of hepatocytes removed during decellularization (Fig. 2g) .
Recellularization of decellularized liver matrix
The presence of a functional vascular bed in the DLM offers the abil ity to control hepatocyte engraftment and characterize liverspecific metabolic function in vitro before transplantation of the recellularized t e c h n i c a l r e p o r t s graft. We introduced primary rat hepatocytes via portal vein per fusion recirculation. Roughly 12.5 million cells were introduced at each step, for a total of four steps, with 10min intervals between each step (Fig. 3a) . Cell viability and distribution in the parenchyma after this fourstep seeding protocol was superior to singlestep infusion of 50 million cells for 40 min (Supplementary Fig. 1a ). Engraftment efficiency with the fourstep protocol was 95.6% ± 3.4%. After seed ing, we transferred the recellularized liver grafts (Fig. 3b,c) into a specially designed perfusion chamber ( Supplementary Fig. 1b) for in vitro culture. The perfusion chamber features two hermetically sealed silicon sheets, forming a pouch filled with culture medium; this design avoids rigid surfaces, preventing development of pressure spots, while enabling sterile culture of the recellularized grafts up to 2 weeks in vitro (data not shown). Histological staining of recellular ized sections at 4 h and at 1 d, 2 d and 5 d of in vitro perfusion culture revealed that at 4 h, the majority of the cells remain in and around the vessels, whereas at 1 d and 2 d, they leave the vessels and get distributed throughout the matrix (Supplementary Fig. 1c ). We did not observe any change in the distribution of the cells within the matrix at 5 d compared to previous days (Supplementary Fig. 1c) . We continuously perfused the recellularized liver graft for 5 d. Hepatocyte viability was maintained during culture, and quantifica tion of TUNELpositive cells revealed that less than 20% of the cells were apoptotic on the first 2 d of culture (Fig. 3d,e) . Lactate dehydro genase (LDH) release during perfusion was comparable and statis tically not different between groups, indicating minimal cell death (P = 0.0455) (Fig. 3f) . SEM and histological analysis (Fig. 3g) showed that hepatocytes engrafted around the larger vessels, populating the surrounding parenchyma, suggesting the cells migrated beyond the matrix barrier to reach decellularized sinusoidal spaces. We assessed the functional characteristics of engrafted hepatocytes in the decellu larized matrix via immunostaining at 2 d of culture of UDP glucuron osyltransferase 1 family, polypeptide A1 (Ugt1a), a sensitive enzyme with a short halflife (about 50 min) whose presence indicated hepato cyte viability and function, glucose6phosphatase, catalytic subunit (G6pc) and albumin (Fig. 3h) . The level of immunostaining for these markers in engrafted hepatocytes was similar to that in normal livers (Fig. 3h) .
To assess the metabolic activity of engrafted hepatocytes, we quantified hepatocyte albu min production and urea synthesis. The cumulative urea amounts in the recellular ized liver system were statistically higher than in hepatocyte sandwich culture during the 5d culture period (P = 0.0017) (Fig. 4a,b) . The difference in cumulative albumin levels was statistically not significant (P = 0.0176) (Fig. 4a,b) . The albumin production rate by the recellularized liver graft was 27.6 ± 7.0 μg million cells per day as compared to 140 μg million cells per day by the normal adult rat liver 29 .
Analysis of the expression of drug metabo lism enzymes (Supplementary Table 2 ) via quantitative RTPCR at 2 d revealed that expression levels of drug metabolism enzymes in the recellularized liver were similar to those measured in sandwich hepatocyte cultures (P = 0.05) (Fig. 4c,d) . As expected at this stage in culture, gene transcription levels were overall much lower than those of freshly isolated hepatocytes (Fig. 4c) . However, Cyp2c11 (encoding cytochrome P450, subfamily 2, polypep tide 11) Gstm2 (glutathione Stransferase mu 2), Ugt1a1 (encoding UDP glucuronosyltransferase1 family, polypeptide A1) and Cyp1a1 (encoding cytochrome P450, family1, subfamily a, polypeptide 1) were expressed in the recellularized liver at similar levels to those in normal liver (Fig. 4e-h ). Adh1 (encoding alcohol dehydrogenase1) and Cyp3a18 (encoding cytochrome P450, family 3, subfamily a, polypeptide 18) expression levels were higher in recellularized liver than in sandwich plate culture control, although they were much lower than in normal liver (Fig. 4i,j) . Primary hepatocytes are known to require between 7 and 10 d in culture before their metabolic activity and gene transcription levels stabilize 30 .
Further scalability of recellularization methodology Ultimately, reconstruction of liver grafts in vitro requires the addi tion of nonparenchymal cells. As a preliminary test, we attempted to seed a nonparenchymal component to the recellularized liver graft by incorporating microvascular endothelial cells to the hepatocyte repopulated graft and tested it by perfusion culture for up to 5 d to allow for endothelial cell engraftment. Histological analysis showed that endothelial cells were capable of lining the vasculature encir cled by hepatocytes at 3 d of culture (Supplementary Fig. 2a-d) . Hepatocytes remained viable, as indicated by TUNEL staining and immunohistochemistry ( Supplementary Fig. 2e-i) .
To test the scalability of the seeding approach, as well as the limits of the perfusionculture system, we repopulated the median lobe of DLM with 200 million hepatocytes and observed the perfusion culture for 10 d. This cellular amount corresponds to approximately 20% of a rat's liver mass, more than double the minimum hepatic mass necessary for therapeutic intervention 6 . In these studies, we injected 50 million hepatocytes at each of the four steps mentioned above. We assessed the metabolic activity of the recellularized liver graft through albumin production, urea secretion and total bile acid synthesis, and the cumulative levels of production of these metabolites were found to be at similar levels to those of static sandwichculture controls t e c h n i c a l r e p o r t s nature medicine VOLUME 16 | NUMBER 7 | JULY 2010 8 1 7
(P = 0.5249, P = 0.5271 and P = 0.0114, respectively), indicating the scalability of the techniques we introduce here, as well as the usability of the perfusionculture system as an in vitro model (Supplementary Fig. 3 ).
Transplantation of recellularized liver grafts
An available functional vascular structure offers the opportunity to transplant the recellularized liver graft by connecting the graft to the blood supply, allowing for the transplantation of a critical hepatocyte mass while avoiding ischemic damage due to poor graft perfusion. Briefly, recipient rats underwent unilateral nephrectomy to prepare a viable site for auxiliary liver graft transplantation. We used the renal vein and artery as ports to create blood flow within the graft. Upon unclamping of the artery, the graft was perfused, quickly filling with blood, and appropriate efflux was established within 5 min (Fig. 5a) .
The recellularized graft was kept in vivo for 8 h before harvesting for further analysis. TUNEL staining revealed that there was mini mal damage to the hepatocytes due to the arterial blood flow and the resulting shear stress during 8 h of transplantation (19.7% ± 13.7% of TUNELpositive cells after transplantation versus 21.4% ± 5.8% of TUNELpositive cells before transplantation, P = 0.55, Supplementary  Fig. 4 ). Histological staining indicated that the hepatocytes retained both normal morphology and their parenchymal positions (Fig. 5b) .
Immunohistochemical staining for albumin, G6pc and Ugt1a confirmed that hepatic function was also retained in the transplanted grafts, with minimal indications of ischemic damage (Fig. 5b) .
To investigate early graft function beyond 8 h, we adopted an ex vivo wholeblood perfusion technique as a surrogate model of trans plantation, which has been shown to be representative of early graft performance and to predict primary graft failure in an orthotopic rat liver transplant model 31, 32 . The ex vivo perfusion system was similar to the in vitro perfusion system, except that the perfusate consisted of whole rat blood diluted with perfusion medium (hematocrit 20%). The recellularized liver graft was perfused for 24 h, during which the blood was replenished three times, once every 8 h to keep the hematocrit level at 20% (Supplementary Fig. 5b) . TUNEL staining and histologi cal analysis showed that hepatocytes remained viable (22.6% ± 13.8% TUNELpositive cells, Supplementary Fig. 5c ) and preserved their morphology and parenchymal position at the end of ex vivo blood per fusion (Supplementary Fig. 5d ). In addition, hepatocytes remained metabolically active during the 24 h ex vivo blood perfusion, as evi denced by urea and albumin secretion (Supplementary Fig. 5e,f) .
DISCUSSION
These results present the first step toward development of recellular ized liver matrix as an auxiliary graft for transplantation. Previous attempts, including those of our group, have failed in creating complex tissueengineered constructs for liver transplantation 16 Oxygen and nutrient transport limitations have thus far restricted the development of tissueengineered liver constructs to the diffusion limit, about 200 μm. The high rates of oxygen consumption [33] [34] [35] [36] by primary hepato cytes result in ischemic damage in cells found further away from the blood within minutes of transplantation. Owing to high oxygen demands, the liver is the only organ that receives both arterial and venous blood supply, whereas hepatocytes are located less than 2 μm distance from the nearest blood vessel 17 . It is a crucial configuration that should ideally be replicated in vitro before transplantation.
This report builds on the previously reported technique developed for heart perfusion decellularization 27 , demonstrating its applicabil ity for rat liver decellularization and further extending its innova tive contributions by introducing a perfusionseeding method and an extracorporeal perfusionculture system. Additionally, we further optimize the decel lularization for liver. Our work shows that portal vein perfusion decellularization creates a translucent liver matrix while preserving the threedimensional architecture, the native structural and basement membrane matrix, and the functional vascular network of the original organ. Portal vein dye perfusion, corrosion casting, SEM and immuno staining show the presence and function of the microvascular network of the liver post decellularization. Quantification of extracellular matrix proteins, SEM analysis and immunostaining suggests that the matrix of both the large vessels (collagen type I, lamininβ1) and the sinusoids (collagen type IV, fibronectin) remained relatively intact. We note that the main structural protein of the liver, collagen type I, was retained in its entirety during the decellularization process. However, we also note the marked loss of half of the glycosaminoglycan content of the liver during decellularization. This loss is not surprising, as many glycosamino glycans are associated with cellular membranes that are solubilized in the decellularization process. We have found that the DLM can be seeded with primary rat hepatocytes via a multistep perfusion technique, with efficiency greater than 90%. As expected, this grafting efficiency is much higher than in vivo levels of engraftment after hepatocyte trans plantation, possibly as a result of the lack of endothelial barrier and the abundant empty space. We seeded 50 million primary rat hepato cytes, roughly 5% of the cells in native rat liver, as this amount was previously shown to be sufficient to restore liver function in animal models 6 . We have also shown that this number can be increased up to 200 million to account for 20% of the native rat liver hepatic mass, corresponding to repopulation of approximately 50% of the original hepatic mass within the lobe used for transplantation. After engraftment, hepatocyte viability and metabolic function was maintained in perfusion culture, as assessed by TUNEL staining, LDH release, synthetic activity and gene expression. Engrafted cells showed albumin production and gene expression equivalent to cells from the same isolation cultured in a collagensandwich configu ration, a culture configuration previously shown to maintain high liverspecific function for up to a month in vitro 37 . Overall, albu min production and gene expression were roughly 20% and 30% of in vivo levels, respectively.
We have shown that rat livers can be depleted of their cellular com ponents and used to engineer sophisticated hepatic structures that may recover many functions of normal liver. Despite its advantages, further improvements of the decellularization and recellularization of liver matrix are necessary. Engineering of an entire liver will require addition of nonparenchymal cells such as liver sinusoidal endothelial cells, stellate cells, biliary epithelial cells and Kupffer cells. Particularly, we observed the presence of hepatocytes outside the microvasculature system, mainly distributed in the parenchymal spaces, possibly owing to loss of sinusoidal integrity in the absence of the liver sinusoidal endothelium and other nonparenchymal cells. We speculate that the nonparenchymal cells of the liver will be essential for reacquisition of vascular integrity. Our ongoing studies are directed toward optimizing seeding strategies, reendothelialization and biliary tract reconstruc tion. However, our preliminary results on reendothelialization of the graft indicate the feasibility of this approach. Addition of nonparen chymal cells and modification of the perfusate may further enhance the reconstitution of a functional liver graft and even lead to hepatic repopulation by imitating the regenerative behavior of the liver. Thus, we envision the possible use of DLM ultimately as a model for the study of both liver development and liver regeneration.
In summary, this report provides a foundation for efficient develop ment of auxiliary liver grafts for transplantation and practical, unique techniques to prepare recellularized liver graft. Further studies are required to determine whether the techniques described here can be scaled up for use in humans.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturemedicine/.
